Perhaps the biggest challenge in precision cancer therapy is tumors’ nasty habit of rebounding after an initial attack with targeted drugs has shrunk them almost out of existence. Instead of vanishing completely, curing the patient, the tumors leave behind a small cadre of cells that slumber in a dormant state, only to return in a … Continued
Watching her deftly maneuver a playground with a huge smile on her face makes it hard to imagine that Anabella Trillo, 3, once faced challenges far greater than a jungle gym. In fact, she has already endured surgery, radiation, chemotherapy, and a stem cell transplant for one of the most aggressive pediatric cancers: a malignant … Continued
This post originally appeared on Discoveries, the blog of Boston Children’s Hospital. A drug used for rheumatoid arthritis has moved a step closer to U.S. Food and Drug Administration (FDA) approval for a desperately needed new use. The drug, abatacept, has gained FDA breakthrough therapy designation for preventing acute, severe graft-versus-host disease (GVHD) in patients receiving bone … Continued
Medically reviewed by Geoffrey Shapiro, MD, PhD, and Christopher French, MD Although it is one of the most aggressive solid tumors in humans, NUT carcinoma responds better to treatment in some patients than others. But because it is rare — with only 20 to 30 cases diagnosed annually in the United States — doctors have … Continued
Medically reviewed by Ann S. LaCasce, MD, MMSc Mantle cell lymphoma is a rare, often aggressive form of non-Hodgkin lymphoma (NHL), a cancer that involves white blood cells known as lymphocytes, which help protect the body from disease. It is named for its origins in the mantle zone — a ring of cells within the … Continued
Medically reviewed by Michael J. Eck, MD, PhD Scientists have captured the most complete picture yet of a key molecular switch that is sometimes jammed in the “on” position in cancers. With the aid of recent advances in a tool known as cryo-electron microscopy, which can obtain crisp 3D images of large biological molecules, Dana-Farber … Continued
Medically reviewed by Robert I. Haddad, MD Strictly speaking, a tumor is an abnormal swelling or enlargement within the body, but the term most commonly refers to a growth of cancerous cells. In the broadest sense, then, a harmless cyst or collection of fluid would be considered a tumor. But when a physician uses the … Continued
Many sports stars have helped support research and care at Dana-Farber by appearing on the WEEI/NESN Jimmy Fund Radio-Telethon presented by Arbella Insurance Foundation, but few have done so quite like pro football wide receiver-turned-broadcaster Jimmy Cefalo. When Cefalo was interviewed on-air during the August 2019 event at Fenway Park, he used the opportunity to share some … Continued
It’s no secret: Cancer treatments are powerful. It’s also no secret that these drugs can also harm healthy cells in the body, which can lead to side effects. It’s not uncommon for patients to feel nauseous or experience a loss of appetite as a result of treatment. While there are medications you can take to … Continued
Medically reviewed by Douglas Rubinson, MD, PhD Anal cancer is a type of cancer that forms in tissues of the anus. The anus is the opening of the rectum to the outside of the body and at the end of the gastrointestinal tract. What is the leading theory on why the incidence rate has risen … Continued
It was a decade that began with the electrifying results of a clinical trial for a revolutionary new cancer therapy and ended with a Nobel Prize in Medicine for very different cancer-related research. In between those dramatic bookends, the 2010s were packed with progress, with discoveries leading to the FDA’s 2017 approval of the first … Continued
Steve Kelley is the quintessential glass half-full guy. Still, he realizes his reaction to learning he had an extremely rare cancer known as central nervous system (CNS) lymphoma may seem unusual. A few weeks after his June 2018 diagnosis, Kelley, then 64, gathered his family and friends together. He didn’t want to focus negatively on … Continued
Medically reviewed by Jochen H. Lorch, MD, MS While 80 to 90 percent of reported thyroid lumps are not cancerous, performing “neck checks” can help you become familiar with what your thyroid looks and feels like, so you can tell your health care professional if you notice any changes. Jochen Lorch, MD, director of the … Continued
Medically reviewed by Martha Wadleigh, MD Leukemia arises from malfunctions in stem cells within the bone marrow that cause abnormal white blood cells to flood into the bloodstream. Leukemias are classified as either myelogenous (also called myeloid) or lymphocytic, depending on which types of white blood cells are affected. What is the difference between these types … Continued
In a small percentage of women, a painful breast lump turns out to be cancer.
For all their potential to curb or even cure some cancers, drugs known as immune checkpoint inhibitors come with a caveat: They’re effective in only a subset of patients. Predicting who those patients are, and understanding why others don’t respond as well, remains a major challenge. In a new study, researchers at Dana-Farber in collaboration … Continued
By Lyndsay McCaffery Recurrence. The word all cancer survivors know and fear. I don’t know about others, but I felt I was the one who was most definitely never getting cancer again. I worked hard to get on the other side of my diagnosis and long recovery. I put in the work writing in a … Continued
Early on an October morning, Shaun Tierney started a promising new treatment for his stage IV kidney cancer. Anxious to tell his longtime oncologist, he texted Toni Choueiri, MD, director of the Lank Center for Genitourinary Oncology at Dana-Farber. What he didn’t expect was that Choueiri would have his own big news: “Kaelin … Nobel … Continued
Von Hippel-Lindau syndrome (VHL) is a rare disorder in which tumors and cysts can arise in multiple organs and tissues. It affects about 10,000 people in the United States and is caused by a mutation in the VHL gene. The vast majority of people with the syndrome inherited a mutated copy of VHL from a … Continued
